Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 839 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | Non Surgical | 26.07 | NA | 941 | 5,797 | 5,777 | ||||||||||||
| 837 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | Non Surgical | 44.13 | NA | 1,740 | 9,813 | 9,001 | ||||||||||||
| 838 | CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | Non Surgical | 29.81 | NA | 1,218 | 6,629 | 6,584 |
DEMOGRAPHIC DETAILS OF DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 4,747 | 81.89 |
| Black | 468 | 8.07 |
| Hispanic | 190 | 3.28 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 2,150 | 37.09 |
| 70 to 74 | 1,435 | 24.75 |
| Less than 65 | 1,254 | 21.63 |
TOP ICD DIAGNOSIS CODES FOR DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| V5811 | Encounter for antineoplastic chemotherapy | 3,448 | 59.48 |
| Z5111 | Encounter for antineoplastic chemotherapy | 2,299 | 39.66 |
| 4019 | Unspecified essential hypertension | 1,753 | 30.24 |
TOP ICD PROCEDURE CODES FOR DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 9925 | Injection Or Infusion Of Cancer Chemotherapeutic Substance | 3,315 | 57.18 |
| 3E04305 | Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach | 1,026 | 17.7 |
| 3E03305 | Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach | 663 | 11.44 |
TOP HOSPITALS ASSOCIATED WITH DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 266 | 4.59 |
| NewYork Presbyterian - Weill Cornell Medical Center | 525 E 68TH ST | New York | NY | 10021 | 99 | 1.71 |
| Duke University Hospital | 2301 ERWIN ROAD | Durham | NC | 27710 | 98 | 1.69 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 56 | 0.97 |
| DR. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 54 | 0.93 |
| DR. ETSUKO AOKI | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 40 | 0.69 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 44 | 0.76 |
| DR. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 42 | 0.72 |
| DR. KAREN PATRICIA SEITER | 19 BRADHURST AVE | HAWTHORNE | NY | 10532 | 38 | 0.66 |
DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | V5811 | Encounter for antineoplastic chemotherapy | NA | 3,448 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | Z5111 | Encounter for antineoplastic chemotherapy | 13,349 | 2,299 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | 4019 | Unspecified essential hypertension | NA | 1,753 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | 20500 | Acute myeloid leukemia, without mention of having achieved remission | NA | 1,570 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | I10 | Essential (primary) hypertension | 2,499 | 1,161 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | 2724 | Other and unspecified hyperlipidemia | NA | 987 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | C9200 | Acute myeloblastic leukemia, not having achieved remission | 2,252 | 843 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | 20501 | Acute myeloid leukemia, in remission | NA | 795 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | V1582 | Personal history of tobacco use | NA | 766 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy | Chemotherapy With Acute Leukemia | 25000 | Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled | NA | 648 |